Skip to main content
Swing Capital

Rossari Biotech Ltd

NSE: ROSSARI BSE: 543213Textile

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

₹499
52W: ₹373 — ₹768
PE 19.4 · Book ₹220 · +127% vs book
Market Cap₹2,765 Cr
Stock P/E19.4Price to Earnings
ROCE16.4%Return on Capital
ROE12.4%Return on Equity
Div. Yield0.1%Face Value ₹2

Weaknesses

  • −Company has a low return on equity of 11.5% over last 3 years.

Shareholding Pattern

Promoters68.15%
FIIs2.18%
DIIs18.21%
Public11.46%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters68.32%68.27%▼0.068.19%▼0.168.18%▼0.068.18%68.18%68.15%▼0.068.15%
FIIs3.83%3.74%▼0.13.74%3.98%▲0.23.48%▼0.52.7%▼0.82.32%▼0.42.18%▼0.1
DIIs16.87%17.34%▲0.517.47%▲0.117.59%▲0.117.84%▲0.318.18%▲0.318.25%▲0.118.21%▼0.0
Public10.98%10.64%▼0.310.6%▼0.010.24%▼0.410.5%▲0.310.95%▲0.411.25%▲0.311.46%▲0.2

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales299314301336368427366420451516
Expenses258272261292318374322369400453
Operating Profit41424044505244505064
OPM %14%13%13%13%14%12%12%12%11%12%
Net Profit26262427313226313155
EPS ₹4.624.744.44.965.535.844.745.645.539.88

AI Insights

Revenue Trend

Mar 2026 revenue at ₹1,752Cr, up 22.3% YoY. OPM at 12%.

Debt Position

Borrowings at ₹144Cr. Debt-to-equity ratio: 0.12x. Healthy balance sheet.

Capex Cycle

CWIP at ₹105Cr (48% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 18.21% (+0.50pp change). FIIs: 2.18% (-3.94pp change). Promoters hold 68.15%.

Margin & Efficiency

ROCE improving from 0% (Mar 2011) to 16% (Mar 2026). Working capital days: 69.

Valuation

PE 19.4x with 16.4% ROCE. Price is 127% above book value of ₹220. Dividend yield: 0.1%.

Recent Announcements